Autori: Kudaba Iveta
| Naslov | Exploratory composite endpoint demonstrates benefit of trilaciclib across multiple clinically meaningful components of myeloprotection in patients with small cell lung cancer (Article) |
| Autori | Domine Gomez Manuel Csoszi Tibor Jaal Jana Kudaba Iveta Nikolov Krassimir Radosavljevic Davorin Z Xiao Jie Horton Janet K Malik Rajesh K Subramanian Janakiraman |
| Info | INTERNATIONAL JOURNAL OF CANCER, (2021), vol. 149 br. 7, str. 1463-1472 |
| Projekat | G1 Therapeutics, Inc. |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
     |
